Orbimed Advisors LLC Geron Corp Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Geron Corp stock. As of the latest transaction made, Orbimed Advisors LLC holds 400,000 shares of GERN stock, worth $1.14 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
400,000
Previous 600,000
33.33%
Holding current value
$1.14 Million
Previous $2.54 Million
28.62%
% of portfolio
0.04%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding GERN
# of Institutions
276Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$133 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$126 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$92.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$92 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$82.5 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.08B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...